Ryali Sriram 4
4 · Eiger BioPharmaceuticals, Inc. · Filed Jul 30, 2021
Insider Transaction Report
Form 4
Ryali Sriram
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-07-29+30,000→ 30,000 totalExercise: $8.15Exp: 2031-07-28→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The option vests in equal monthly installments over 36 months measured from July 29, 2021 subject to Reporting Person's continuous service status as of each such date.